| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ICARES Medicus Inc (TWO: 6612)
6612 Technical Analysis
5
| As on 22nd Dec 2025 6612 STOCK Price closed @ 74.60 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 113.29 & Strong Sell for SHORT-TERM with Stoploss of 122.63 we also expect STOCK to react on Following IMPORTANT LEVELS. |
6612STOCK Price
| Open | 76.70 | Change | Price | % |
| High | 77.00 | 1 Day | -2.30 | -2.99 |
| Low | 74.50 | 1 Week | -7.70 | -9.36 |
| Close | 74.60 | 1 Month | -13.40 | -15.23 |
| Volume | 53926 | 1 Year | -43.40 | -36.78 |
| 52 Week High 132.50 | 52 Week Low 74.60 | ||||
TWO Taiwan Most Active Stocks
| 5498 | 40.55 | 9.89% |
| 1815 | 86.50 | 7.05% |
| 5309 | 72.20 | 3.29% |
| 4979 | 265.00 | 9.50% |
| 3105 | 191.00 | 9.77% |
| 8074 | 45.95 | 6.24% |
| 3260 | 200.00 | 6.10% |
| 3211 | 343.00 | 3.31% |
| 6127 | 33.90 | 3.35% |
| 6274 | 454.00 | 6.32% |
TWO Taiwan Top Gainers Stocks
TWO Taiwan Top Losers Stocks
| 6612 Daily Charts |
6612 Intraday Charts |
Whats New @ Bazaartrend |
6612 Free Analysis |
|
|
6612 Important Levels Intraday
| RESISTANCE | 79.42 |
| RESISTANCE | 77.87 |
| RESISTANCE | 76.92 |
| RESISTANCE | 75.96 |
| SUPPORT | 73.24 |
| SUPPORT | 72.28 |
| SUPPORT | 71.33 |
| SUPPORT | 69.78 |
6612 Forecast December 2025
| 4th UP Forecast | 110.25 |
| 3rd UP Forecast | 98.82 |
| 2nd UP Forecast | 91.75 |
| 1st UP Forecast | 84.68 |
| 1st DOWN Forecast | 64.52 |
| 2nd DOWN Forecast | 57.45 |
| 3rd DOWN Forecast | 50.38 |
| 4th DOWN Forecast | 38.95 |
6612 Weekly Forecast
| 4th UP Forecast | 89.05 |
| 3rd UP Forecast | 84.42 |
| 2nd UP Forecast | 81.55 |
| 1st UP Forecast | 78.69 |
| 1st DOWN Forecast | 70.51 |
| 2nd DOWN Forecast | 67.65 |
| 3rd DOWN Forecast | 64.78 |
| 4th DOWN Forecast | 60.15 |
6612 Forecast2025
| 4th UP Forecast | 193.11 |
| 3rd UP Forecast | 155.1 |
| 2nd UP Forecast | 131.61 |
| 1st UP Forecast | 108.12 |
| 1st DOWN Forecast | 41.08 |
| 2nd DOWN Forecast | 17.59 |
| 3rd DOWN Forecast | -5.9 |
| 4th DOWN Forecast | -43.91 |
ICARES Medicus Inc ( TWO Taiwan Symbol : 6612 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
6612 Other Details
| Segment | EQ | |
| Market Capital | 2065376000.00 | |
| Sector | Healthcare | |
| Industry | Medical Instruments & Supplies | |
| Offical website | > echo $website ; ?> | |
6612 Address
![]() |
||
6612 Latest News
6612 Business Profile
ICARES Medicus, Inc. engages in the research and development, manufacture, and sale of ophthalmic medical materials. The company provides nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices; intraocular lenses for the treatment of cataracts, myopia, hyperopia, presbyopia, or astigmatism; and nanomedical devices. It has operations in the United States, England, Japan, Taiwan, Spain, Hungary, China, and internationally. The company was founded in 2011 and is based in Zhubei, Taiwan. Address: No. 16, Sheng Yi Road, Zhubei, Taiwan
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

